Prediction of vascular risk after stroke - protocol and pilot data of the prospective Cohort with incident stroke (PROSCIS)

International Journal of Stroke

Volumn 8, Issue 6, 2013, Pages 484-490

  Liman, Thomas G ^a   Zietemann, Vera ^b   Wiedmann, Silke ^a,c   Jungehuelsing, Gerhard J ^a   Endres, Matthias ^a   Wollenweber, Frank A ^b   Wellwood, Ian ^a   Dichgans, Martin ^b   Heuschmann, Peter U ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cohort study; First ever stroke; Prediction; Stroke epidemiology; Stroke related outcomes

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; EXTERNAL VALIDITY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCORING SYSTEM; VASCULAR DEATH; VASCULAR DISEASE;

COHORT STUDY; FIRST-EVER STROKE; PREDICTION; STROKE EPIDEMIOLOGY; STROKE-RELATED OUTCOMES;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL PROTOCOLS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; PILOT PROJECTS; PROGNOSIS; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; STROKE; VASCULAR DISEASES; YOUNG ADULT;

EID: 84881500526     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2012.00871.x     Document Type: Article

References (43)

1. Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke 2011; 42:1489-1494.
2. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 2005; 36:2748-2755.
3. Wijnhoud AD, Maasland L, Lingsma HF, Steyerberg EW, Koudstaal PJ, Dippel DW. Prediction of major vascular events in patients with transient ischemic attack or ischemic stroke: a comparison of 7 models. Stroke 2010; 41:2178-2185.
4. Weimar C, Benemann J, Michalski D etal. Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores. Stroke 2010; 41:487-493.
5. Weimar C, Diener HC, Alberts MJ etal. The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke 2009; 40:350-354.
6. Fitzek S, Leistritz L, Witte OW, Heuschmann PU, Fitzek C. The Essen Stroke Risk Score in one-year follow-up acute ischemic stroke patients. Cerebrovasc Dis 2011; 31:400-407.
7. Weimar C, Goertler M, Rother J etal. Predictive value of the Essen Stroke Risk Score and Ankle Brachial Index in acute ischaemic stroke patients from 85 German stroke units. J Neurol Neurosurg Psychiatry 2008; 79:1339-1343.
8. Kernan WN, Viscoli CM, Brass LM etal. The stroke prognosis instrument II (SPI-II): a clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke 2000; 31:456-462.
9. Johnston SC, Rothwell PM, Nguyen-Huynh MN etal. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369:283-292.
10. Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neurol Neurosurg Psychiatry 1992; 55:640-652.
11. Pendlebury ST, Rothwell PM. Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis 2009; 27(Suppl. 3):1-11.
12. Nambi V, Hoogeveen RC, Chambless L etal. Lipoprotein-associated phospholipase A2 and high-sensitivity C-reactive protein improve the stratification of ischemic stroke risk in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2009; 40:376-381.
13. Mohan KM, Crichton SL, Grieve AP, Rudd AG, Wolfe CD, Heuschmann PU. Frequency and predictors for the risk of stroke recurrence up to 10 years after stroke: the South London Stroke Register. J Neurol Neurosurg Psychiatry 2009; 80:1012-1018.
14. Adams HP Jr, Bendixen BH, Kappelle LJ etal. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
15. Amarenco P, Bogousslavsky J, Caplan LR, Donnan GA, Hennerici MG. New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. Cerebrovasc Dis 2009; 27:502-508.
16. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001; 32:2735-2740.
17. Steyerberg EW, Vickers AJ, Cook NR etal. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21:128-138.
18. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006; 145:21-29.
19. Paynter NP, Mazer NA, Pradhan AD, Gaziano JM, Ridker PM, Cook NR. Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. Arch Intern Med 2011 Oct 24; 171 (19):1712-1718.
20. Fowkes FG, Murray GD, Butcher I etal. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300:197-208.
21. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54:541-553.
22. Roger PR, Johnson-Greene D. Comparison of assessment measures for post-stroke depression. Clin Neuropsychol 2009; 23:780-793.
23. Godefroy O, Fickl A, Roussel M etal. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment?: a study with neuropsychological evaluation. Stroke 2011; 42:1712-1716.
24. Liman TG, Heuschmann PU, Endres M, Floel A, Schwab S, Kolominsky-Rabas PL. Changes in cognitive function over 3 years after first-ever stroke and predictors of cognitive impairment and long-term cognitive stability: the Erlangen Stroke Project. Dement Geriatr Cogn Disord 2011; 31:291-299.
25. Oldenbeuving AW, de Kort PL, Jansen BP, Algra A, Kappelle LJ, Roks G. Delirium in the acute phase after stroke: incidence, risk factors, and outcome. Neurology 2011; 76:993-999.
26. Barber M, Stott DJ. Validity of the Telephone Interview for Cognitive Status (TICS) in post-stroke subjects. Int J Geriatr Psychiatry 2004; 19:75-79.
27. Cook DG, Shaper AG, MacFarlane PW. Using the WHO (Rose) angina questionnaire in cardiovascular epidemiology. Int J Epidemiol 1989; 18:607-613.
28. Berger K, Hense HW, Rothdach A, Weltermann B, Keil U. A single question about prior stroke versus a stroke questionnaire to assess stroke prevalence in populations. Neuroepidemiology 2000; 19:245-257.
29. Greenland P, Abrams J, Aurigemma GP etal. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation 2000; 101:E16-22.
30. Busch MA, Lutz K, Rohl JE, Neuner B, Masuhr F. Low ankle-brachial index predicts cardiovascular risk after acute ischemic stroke or transient ischemic attack. Stroke 2009; 40:3700-3705.
31. Yu CM, Zhang Q, Lam L etal. Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease. Heart 2007; 93:933-939.
32. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med 1998; 17:1623-1634.
33. Pencina MJ, D'Agostino RB, Vasan RS. Statistical methods for assessment of added usefulness of new biomarkers. Clin Chem Lab Med 2010; 48:1703-1711.
34. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, Springer, 2009.
35. Cook NR. Assessing the Incremental Role of Novel and Emerging Risk Factors. Curr Cardiovasc Risk Rep 2010; 4:112-119.
36. Cook NR, Paynter NP. Performance of reclassification statistics in comparing risk prediction models. Biom J 2011; 53:237-258.
37. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med 2009; 150:795-802.
38. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172; discussion 207-12.
39. Pencina MJ, D'Agostino RB Sr, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2011; 30:11-21.
40. Uno H, Tian L, Cai T, Kohane IS, Wei LJ. Comparing risk scoring systems beyond the ROC paradigm in survival analysis. Harvard University Biostatistics Working Paper Series 2009; paper 107; accessed online on September 16 2009.
41. Pepe MS. Problems with risk reclassification methods for evaluating prediction models. Am J Epidemiol 2011; 173:1327-1335.
42. Pepe MS, Janes H. Commentary: reporting standards are needed for evaluations of risk reclassification. Int J Epidemiol 2011; 40:1106-1108.
43. Tzoulaki I, Liberopoulos G, Ioannidis JP. Use of reclassification for assessment of improved prediction: an empirical evaluation. Int J Epidemiol 2011; 40:1094-1105.